Armata Pharmaceuticals (ARMP) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.80% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -3.84% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.53% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 47.10% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -99.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.67% |
| Dec 31, 2025 | -129.27% |
| Sep 30, 2025 | -45.76% |
| Jun 30, 2025 | -20.93% |
| Mar 31, 2025 | 9.37% |
| Dec 31, 2024 | 34.44% |
| Sep 30, 2024 | -0.38% |
| Jun 30, 2024 | 51.11% |
| Mar 31, 2024 | -65.75% |
| Dec 31, 2023 | -44.16% |
| Sep 30, 2023 | -75.46% |
| Jun 30, 2023 | 9.02% |
| Mar 31, 2023 | -41.84% |
| Dec 31, 2022 | -66.84% |
| Sep 30, 2022 | -7.39% |
| Jun 30, 2022 | -29.95% |
| Mar 31, 2022 | -32.89% |
| Dec 31, 2021 | -76.43% |
| Sep 30, 2021 | -25.05% |
| Jun 30, 2021 | -25.06% |
| Mar 31, 2021 | -20.58% |
| Dec 31, 2020 | -41.22% |
| Sep 30, 2020 | -94.92% |
| Jun 30, 2020 | 10.00% |
| Mar 31, 2020 | -16.09% |
| Dec 31, 2019 | 34.08% |
| Sep 30, 2019 | -43.07% |
| Jun 30, 2019 | -2.93% |
| Mar 31, 2019 | -6.31% |
| Dec 31, 2018 | 20.98% |
| Sep 30, 2018 | -35.89% |
| Jun 30, 2018 | -31.89% |
| Mar 31, 2018 | 39.98% |
| Dec 31, 2017 | -52.44% |
| Sep 30, 2017 | -26.76% |
| Jun 30, 2017 | -35.10% |
| Mar 31, 2017 | 34.03% |
| Dec 31, 2016 | -183.32% |
| Sep 30, 2016 | 63.48% |
| Jun 30, 2016 | 35.93% |